Global Medical REIT Inc (NYSE:GMRE) was downgraded by Compass Point from a “buy” rating to a “neutral” rating in a report released on Tuesday, StockTargetPrices.com reports.

Separately, DA Davidson restated a “buy” rating on shares of Global Medical REIT in a research note on Monday, July 25th.

Global Medical REIT (NYSE:GMRE) traded down 2.445% during mid-day trading on Tuesday, hitting $10.175. The stock had a trading volume of 77,962 shares. The stock’s market cap is $179.13 million. The firm has a 50-day moving average of $10.62 and a 200-day moving average of $10.55. Global Medical REIT has a 52-week low of $9.52 and a 52-week high of $11.38.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/compass-point-downgrades-global-medical-reit-inc-gmre-to-neutral.html

About Global Medical REIT

5 Day Chart for NYSE:GMRE

Stock Target Prices

Receive News & Ratings for Global Medical REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc and related companies with MarketBeat.com's FREE daily email newsletter.